Abstract
Transgenic plants are showing considerable potential for the economic production of proteins, with a few already being marketed. Recent clinical trials of pharmaceuticals produced from transgenic plants are encouraging, with plant glycans showing reassuringly poor immunogenicity. Our increasing understanding of protein targeting and accumulation should further improve the potential of this new technology.
| Original language | English |
|---|---|
| Pages (from-to) | 450-454 |
| Number of pages | 5 |
| Journal | Current Opinion in Biotechnology |
| Volume | 12 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 01 Oct 2001 |
Fingerprint
Dive into the research topics of 'Transgenic plants as protein factories'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver